What is the recommended evaluation and management for a young adult female attorney with persistent fatigue and non‑restorative sleep despite 8–9 hours of sleep, a 60‑minute sleep latency, night sweats, evening energy surge, reflux‑related cough, occasional bruxism, on escitalopram (Lexapro) and bupropion (Wellbutrin), Epworth Sleepiness Scale 12, and no evidence of obstructive sleep apnea?

Primary Diagnosis: Chronic Insomnia Disorder with Prolonged Sleep Onset Latency

This patient has chronic insomnia disorder, not a primary sleep disorder causing her fatigue, and should be treated with cognitive behavioral therapy for insomnia (CBT-I) as first-line therapy 1.

Clinical Reasoning

Distinguishing Fatigue from Sleepiness

This patient reports fatigue, not true excessive daytime sleepiness 2. Key distinguishing features:

• Epworth Sleepiness Scale of 12 is only mildly elevated (normal <10), not indicative of pathological sleepiness
• Denies napping despite feeling tired—patients with true hypersomnolence cannot resist sleep
• Reports feeling "tired" and "unrefreshed" rather than uncontrollable sleep episodes
• Most sleepy in early morning (4:30-11 AM) when she's actually awake, not during typical waking hours

Insomnia Diagnosis Confirmed

The patient meets diagnostic criteria for chronic insomnia disorder 1:

• Sleep onset latency of 60 minutes (prolonged; normal <30 minutes)
• Difficulty returning to sleep after nocturnal awakenings
• Non-restorative sleep despite adequate sleep duration (8-9 hours)
• Symptoms present for >3 months
• Causes daytime impairment (persistent fatigue)

Ruling Out Other Sleep Disorders

Obstructive sleep apnea is effectively excluded:

• Denies snoring, witnessed apneas, gasping, choking
• No morning headaches or dry mouth
• Low body weight (107-110 lbs)
• ESS only 12 (moderate-to-severe OSA typically >15)

Insufficient sleep syndrome is ruled out 3:

• Total sleep time of 8-9 hours weekdays, 12 hours weekends exceeds recommended duration
• The issue is sleep quality, not quantity
• Weekend "catch-up" sleep doesn't improve symptoms (unlike insufficient sleep syndrome)

Circadian rhythm disorder (delayed sleep phase) is unlikely:

• Bedtime 11 PM is not significantly delayed
• Works successfully as an attorney with 7:30 AM wake time
• No mention of inability to function at work

Recommended Evaluation

Immediate Assessment Required

1. Actigraphy for 1-2 weeks to objectively document:

   • Actual sleep-wake patterns vs. patient perception
   • Sleep onset latency
   • Weekend vs. weekday patterns
   • Rule out sleep state misperception 3, 4

2. Medication review focusing on insomnia-inducing effects:

   • Bupropion (Wellbutrin) is activating and commonly causes insomnia, particularly when recently started 5
   • Timing of Lexapro dose (if taken at night, may cause activation in some patients)
   • Consider if recent Wellbutrin addition temporally correlates with worsening symptoms

3. Evaluate contributing medical factors:

   • Gastroesophageal reflux with bedtime cough disrupts sleep onset and maintenance—requires aggressive treatment
   • Bruxism indicates sleep fragmentation and possible anxiety manifestation
   • Night sweats warrant evaluation for:
     • Medication side effects (SSRIs can cause night sweats) 5
     • Perimenopausal symptoms if age-appropriate
     • Anxiety/panic disorder nocturnal manifestations

4. Psychiatric assessment:

   • Anxiety and depression are present and strongly associated with insomnia 1
   • Recent medication changes may indicate inadequate psychiatric symptom control
   • Evening energy surge may represent anxiety-driven hyperarousal

Polysomnography is NOT indicated

• No clinical features suggesting OSA, narcolepsy, REM behavior disorder, or periodic limb movements
• Guidelines do not recommend PSG for uncomplicated insomnia 1

Treatment Algorithm

Step 1: First-Line Treatment (Initiate Immediately)

Cognitive Behavioral Therapy for Insomnia (CBT-I) 1:

• Strong recommendation, moderate-quality evidence for chronic insomnia
• Can be delivered via individual therapy, group sessions, telephone, web-based modules, or self-help books
• Components include:
  • Sleep restriction therapy: Limit time in bed to actual sleep time (initially ~7.5 hours based on her sleep efficiency), gradually increase
  • Stimulus control: Bed only for sleep and sex; leave bedroom if not asleep within 20 minutes
  • Cognitive therapy: Address anxiety about sleep, catastrophic thinking about fatigue
  • Sleep hygiene: Already partially addressed (no alcohol abuse, limited caffeine)

Step 2: Address Contributing Factors (Concurrent with CBT-I)

Optimize medication regimen:

• Consider timing adjustment or discontinuation of Bupropion if temporally related to insomnia onset
  • Bupropion is activating and frequently causes insomnia
  • If needed for depression, take in morning only, never after 3 PM
  • Alternative: switch to different antidepressant with less insomnia risk if depression inadequately controlled

Treat gastroesophageal reflux aggressively:

• Proton pump inhibitor therapy
• Elevate head of bed
• Avoid eating 3 hours before bedtime
• This directly addresses bedtime cough disrupting sleep onset

Address bruxism:

• Dental guard if not already using
• May indicate inadequate anxiety management

Manage night sweats:

• If medication-related (SSRI), consider dose adjustment or alternative
• If perimenopausal, consider appropriate hormonal evaluation

Step 3: Pharmacotherapy (Only if CBT-I Insufficient After 4-6 Weeks)

The guideline recommends shared decision-making for short-term pharmacotherapy only after CBT-I failure 1. Options in order of preference:

1. Eszopiclone or zolpidem (low-quality evidence for efficacy; FDA-approved for short-term use)

   • Caution: Risk of daytime impairment, complex sleep behaviors, tolerance
   • Use lowest effective dose
   • Maximum 4-5 weeks

2. Doxepin (low-dose 3-6 mg) for sleep maintenance insomnia

   • Moderate evidence in older adults
   • Less abuse potential than benzodiazepines

3. Suvorexant (orexin antagonist)

   • Moderate evidence for efficacy
   • May be better tolerated than traditional hypnotics

NOT recommended 6, 1:

• Melatonin: No evidence for chronic insomnia (only 7-minute reduction in sleep latency)
• Valerian, chamomile: No evidence of efficacy
• Kava: Risk of acute liver toxicity—strong recommendation against
• Quetiapine or other antipsychotics: Sparse evidence, serious harms including mortality risk
• Benzodiazepines: Insufficient evidence, significant harm profile
• Diphenhydramine, trazodone: Not adequately studied despite common use

Step 4: Reassess Psychiatric Treatment

• Current anxiety/depression may be inadequately controlled given recent medication addition
• Consider psychiatric consultation if symptoms persist despite optimized sleep treatment
• Evening energy surge suggests possible hyperarousal/anxiety component requiring specific treatment

Critical Pitfalls to Avoid

1. Do not prescribe sleep medications without attempting CBT-I first 1—this is a strong guideline recommendation

2. Do not order polysomnography—not indicated for uncomplicated insomnia and wastes resources 1

3. Do not attribute symptoms to "insufficient REM sleep"—this is not a validated clinical entity; focus on insomnia diagnosis

4. Do not overlook medication-induced insomnia—recently started Bupropion is a prime suspect

5. Do not ignore reflux symptoms—bedtime cough directly disrupts sleep onset and must be treated

6. Do not use over-the-counter sleep aids long-term—no evidence for efficacy in chronic insomnia 6

7. Recognize this is NOT excessive daytime sleepiness—ESS of 12 with no napping indicates fatigue from poor sleep quality, not a hypersomnolence disorder 2, 7